Analysis: Pfizer tallies an impressive array of late-stage catalysts for cancer, gene therapies and more – Endpoints News
|
Analysis: Pfizer tallies an impressive array of late-stage catalysts for cancer, gene therapies and more
Endpoints News Pfizer and its partners at Astellas are anxious to get the FDA review underway for nonmetastatic prostate cancer, which could add considerably to its franchise value as generics start to slice and dice the market for J&J’s rival therapy Zytiga. J&J has … |
Genetic Literacy Project |
Finding a CRISPR delivery route in humans is the hard part
Genetic Literacy Project Crispr, the promising new gene editing technology, promises to eradicate the world of human suffering—but for all the hype and hope, it hasn’t actually cured humans of anything, yet. Medical researchers have the cargo, now they just have to figure out … |
|
Search and destroy: CAR–T cell therapy could give patients HIV immunity
Genetic Literacy Project When the CD4 part of the CAR molecule binds to HIV, other regions of the CAR molecule signal the cell to become activated and kill the HIV infected cell. … The approach could ultimately reduce people’s dependence on antiviral medications, lower the … |